ASX - By Stock
|
DXB |
Re:
Ann: AGM Presentation
|
|
singhgu
|
77 |
26K |
3 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
77
|
26K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: AGM Presentation
|
|
singhgu
|
77 |
26K |
5 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
77
|
26K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: AGM Presentation
|
|
singhgu
|
77 |
26K |
4 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
77
|
26K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
singhgu
|
423 |
152K |
4 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
423
|
152K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
singhgu
|
423 |
152K |
9 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
423
|
152K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
singhgu
|
423 |
152K |
0 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
423
|
152K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
singhgu
|
423 |
152K |
23 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
423
|
152K
|
23
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma
|
|
singhgu
|
155 |
41K |
5 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
155
|
41K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma
|
|
singhgu
|
155 |
41K |
23 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
155
|
41K
|
23
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Entitlement Offer Documents
|
|
singhgu
|
20 |
7.6K |
0 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
20
|
7.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
singhgu
|
91 |
25K |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
91
|
25K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
singhgu
|
236 |
90K |
4 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
236
|
90K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
singhgu
|
236 |
90K |
7 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
236
|
90K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
singhgu
|
236 |
90K |
17 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
236
|
90K
|
17
|
|
ASX - By Stock
|
AGN |
Re:
Ann: ARG-007 Inhibits Cause of Alzheimer's in Pre-Clinical Study
|
|
singhgu
|
22 |
8.9K |
1 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
22
|
8.9K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: ARG-007 Inhibits Cause of Alzheimer's in Pre-Clinical Study
|
|
singhgu
|
22 |
8.9K |
1 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
22
|
8.9K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Trading Halt
|
|
singhgu
|
10 |
3.0K |
0 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
10
|
3.0K
|
0
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
singhgu
|
11K |
4.0M |
2 |
07/11/23 |
07/11/23 |
General
|
11K
|
4.0M
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma
|
|
singhgu
|
155 |
41K |
9 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
155
|
41K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
singhgu
|
231 |
68K |
44 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
231
|
68K
|
44
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma
|
|
singhgu
|
155 |
41K |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
155
|
41K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
singhgu
|
423 |
152K |
6 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
423
|
152K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
singhgu
|
423 |
152K |
8 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
423
|
152K
|
8
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
4 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
136
|
33K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
singhgu
|
62 |
22K |
12 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
62
|
22K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
singhgu
|
156 |
53K |
2 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
156
|
53K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
136
|
33K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
singhgu
|
423 |
152K |
5 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
423
|
152K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
singhgu
|
161 |
77K |
5 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
161
|
77K
|
5
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Trading Halt
|
|
singhgu
|
10 |
3.0K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
10
|
3.0K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
17 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
136
|
33K
|
17
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
singhgu
|
11K |
4.0M |
1 |
02/11/23 |
02/11/23 |
General
|
11K
|
4.0M
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
5 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
136
|
33K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
9 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
136
|
33K
|
9
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints U.S. Based Leadership
|
|
singhgu
|
10 |
4.3K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
10
|
4.3K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
8 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
136
|
33K
|
8
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
23 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
136
|
33K
|
23
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
14 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
136
|
33K
|
14
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
singhgu
|
37 |
10K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
37
|
10K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
singhgu
|
37 |
10K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
37
|
10K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
136
|
33K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
136
|
33K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
18 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
136
|
33K
|
18
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
9 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
136
|
33K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
10 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
136
|
33K
|
10
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
136
|
33K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
136
|
33K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
singhgu
|
136 |
33K |
6 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
136
|
33K
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
singhgu
|
22K |
7.7M |
24 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
22K
|
7.7M
|
24
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
singhgu
|
197 |
81K |
0 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
197
|
81K
|
0
|
|